Cemsidomide

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameCemsidomide
Drug Alias NameCFT-7455CFT7455
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Molecular Glue
Mechanisms of ActionProteolysisZinc finger protein Aiolos degradersDNA-binding protein Ikaros degraders
TargetsZinc finger protein AiolosDNA-binding protein Ikaros
Therapy Area/IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesC4 Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesC4 Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma, Non-Hodgkin
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A